Dhalla N S, Lee S L
Br J Pharmacol. 1976 Jun;57(2):215-21. doi: 10.1111/j.1476-5381.1976.tb07470.x.
1 The effects of acebutolol, practolol and propranolol (0,5-3 mM) on calcium uptake, calcium binding and ATPase activities of the rabbit and rat heart microsomal and mitochondrial fractions were investigated. 2 Dose-response and time course experiments revealed that propranolol greatly inhibited microsomal and mitochondrial calcium uptake whereas both acebutolol and practolol showed slight depressant effects. 3 The ATPase activities of microsomal and mitochondrial fractions were decreased by acebutolol, practolol and propranolol; however, the latter agent was more effective than the other two. 4 The inhibitory effects of acebutolol, practolol and propranolol on mitochondria and microsomes were not antagonized by adrenaline. 5 Propranolol decreased calcium binding by the microsomal fraction only, whereas acebutolol and practolol had no effect on microsomal or mitochondrial calcium binding. 6 The sensitivity of the rabbit heart subcellular fractions to the beta-adrenoceptor blocking drugs was similar to that of the rat heart; however, the calcium uptake and ATPase activities of microsomes were more sensitive to propranolol than mitochondria in both species. 7 Perfusion of rat hearts with 0.2-1 mM propranolol decreased contractile force, and microsomal and mitochondrial fractions obtained from these hearts accummulated less calcium in comparison to the control. On the other hand, acebutolol and practolol (0.2-1nM) had no appreciable effects on contractile force or subcellular fractions under similar conditions. 8 The negative inotropic effect of propranolol may partly be due to its inhibitory actions on calcium transport by subcellular organelles of the myocardium; the depressant action of propranolol on calcium transport is unlikely to be due to its beta-adrenoceptor blocking property.
研究了醋丁洛尔、普拉洛尔和普萘洛尔(0.5 - 3 mM)对兔和大鼠心脏微粒体及线粒体部分的钙摄取、钙结合和ATP酶活性的影响。
剂量反应和时间进程实验表明,普萘洛尔极大地抑制微粒体和线粒体的钙摄取,而醋丁洛尔和普拉洛尔均显示出轻微的抑制作用。
醋丁洛尔、普拉洛尔和普萘洛尔均降低了微粒体和线粒体部分的ATP酶活性;然而,后一种药物比其他两种更有效。
醋丁洛尔、普拉洛尔和普萘洛尔对线粒体和微粒体的抑制作用未被肾上腺素拮抗。
普萘洛尔仅降低微粒体部分的钙结合,而醋丁洛尔和普拉洛尔对微粒体或线粒体的钙结合无影响。
兔心脏亚细胞部分对β - 肾上腺素受体阻断药物的敏感性与大鼠心脏相似;然而,在这两个物种中,微粒体的钙摄取和ATP酶活性对普萘洛尔比对线粒体更敏感。
用0.2 - 1 mM普萘洛尔灌注大鼠心脏会降低收缩力,与对照组相比,从这些心脏获得的微粒体和线粒体部分积累的钙更少。另一方面,在类似条件下,醋丁洛尔和普拉洛尔(0.2 - 1 nM)对收缩力或亚细胞部分没有明显影响。
普萘洛尔的负性肌力作用可能部分归因于其对心肌亚细胞器钙转运的抑制作用;普萘洛尔对钙转运的抑制作用不太可能归因于其β - 肾上腺素受体阻断特性。